We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01266668
Recruitment Status : Completed
First Posted : December 24, 2010
Last Update Posted : November 29, 2011
Information provided by (Responsible Party):
Ho-Young Yhim, Chonbuk National University Hospital